Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint
Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint
Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint
Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint
Morning Movers: Ionis and AstraZeneca sink after trial misses endpoint